Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
12/2003
12/16/2003US6664260 Heterocyclic ether substituted imidazoquinolines
12/16/2003US6664247 Pyrazole compounds useful as protein kinase inhibitors
12/16/2003US6664241 Water-soluble amide derivatives of polyene macrolides and preparation and uses thereof
12/16/2003US6664238 Such as 11-Deoxy-5-O-desosaminyl-11-(3,3-dimethyl-3-(4-pyridin-3-yl-imidazol-1-yl -propyl))hydrazo-6-O-methyl-3-oxoerythronolide A,11,12-carbamate, 9-E-(O-methyl)oxime; antibacterial and antiprotozoal agents
12/16/2003US6664235 Medicaments comprising sialic acid derivatives as active ingredients
12/16/2003US6664231 Based on Domain III (amino acids 142-169) of bactericidal/ permeability-increasing protein; candida, aspergillus, cryptococcus
12/16/2003US6664230 Orally administered peptides to ameliorate atherosclerosis
12/16/2003US6664229 Methods for treatment using novel ligands of the neuropeptide receptor HFGAN72
12/16/2003US6664058 A nucleotide, e.g., 6-(beta-D-2-Deoxyribofuranosyl)-5-hydro-methyl-8H-pyrimido(4,5 -c)(1,2)pyridazin-7-one-5'-triphosphate, incorporated into a polynuceotide or an oligomucleotide; viricides; labels
12/16/2003US6664040 Complexing to polypeptides; antiproliferation agent
12/16/2003US6663901 Itraconazole; sugar core, a coating film of a water soluble polymer, a seal coating
12/16/2003US6663897 Oral itraconazole formulations and methods of making the same
12/16/2003US6663879 Injectable compositions
12/16/2003US6663878 Anti-inflammatory bioactive glass particulates
12/16/2003US6663873 Antigenic preparation for treatment or prevention of helicobacter infection
12/16/2003US6663871 Non-replicating or replication- impaired pox virus vector carrying at least one CD8 T cell epitope which is also present in the priming composition, malaria
12/16/2003CA2195125C Difluorostatone antiviral agents
12/16/2003CA2178272C Antiviral monocyclic polyamines
12/16/2003CA2134751C Monoclonal antibodies and their use
12/16/2003CA2088788C Peptides that block human immunodeficiency virus infections and methods of use thereof
12/16/2003CA2087085C Esters of acyl carnitines with long-chain aliphatic alcohols and pharmaceutical compositions containing same having antibacterial activity
12/16/2003CA2072627C Recombinant herpes simplex viruses vaccines and methods
12/14/2003CA2430259A1 Vaccine
12/11/2003WO2003102237A1 Treatment with cytokines
12/11/2003WO2003102207A2 Novel multimeric molecules, the preparation method thereof and use of same for the preparation of medicaments
12/11/2003WO2003102187A1 Self-coalescing or self-aggregating proteins derived from a membrane translocating sequence
12/11/2003WO2003102170A1 Strains of bordetella made deficient by means of genetic attenuation
12/11/2003WO2003102168A1 Attenuated listeria spp. and methods for using the same
12/11/2003WO2003102138A2 Elongase genes and uses thereof
12/11/2003WO2003102010A1 3-descladinosyl-6-o-carbamoyl and 6-o-carbonoyl macrolide antibacterial agents
12/11/2003WO2003101996A2 Esters in position 20 of camptothecins
12/11/2003WO2003101995A2 Camptothecins with a modified lactone ring
12/11/2003WO2003101993A1 Pyrazolo` 1,5a! pyrimidine compounds as antiviral agents
12/11/2003WO2003101989A1 Inhibitors of jak and cdk2 protein kinases
12/11/2003WO2003101987A1 3-substituted quinuclidines and their use
12/11/2003WO2003101981A1 Novel substituted indoles
12/11/2003WO2003101980A1 1,3,5-triazine derivatives as ligands for human adenosine-a3 receptors
12/11/2003WO2003101964A1 Piperidine derivative, process for producing the same, and use
12/11/2003WO2003101957A1 New salts
12/11/2003WO2003101484A1 Compositions and methods for transepithelial molecular transport
12/11/2003WO2003101482A2 Liposome vaccine formulations for fin-fish
12/11/2003WO2003101481A1 Treatment of neurodegenerative diseases using proteasome modulators
12/11/2003WO2003101479A1 Compositions for therapeutic use comprising a vitamin, a metal salt and insulin or a growth hormone
12/11/2003WO2003101478A1 Treatment of hepatitis c in the asian population with subcutaneous interferonbeta
12/11/2003WO2003101467A1 Pharmaceutical compositions comprising abacavir and lamivudine
12/11/2003WO2003101463A1 Method and agent for the prevention, inhibition and treatment of sepsis
12/11/2003WO2003101457A1 Peritoneal dialysis solution with taurolidine
12/11/2003WO2003101453A1 Triple monoamine reuptake inhibitors for the treatment of chronic pain
12/11/2003WO2003101438A1 Treatment for human papillomavirus
12/11/2003WO2003101424A1 Modified release pharmaceutical formulation
12/11/2003WO2003101399A2 Novel bacterium for treatment of disease
12/11/2003WO2003101394A2 Defensins: use as antiviral agents
12/11/2003WO2003101392A2 Novel conazole crystalline forms and related processes, pharmaceutical compositions and methods
12/11/2003WO2003101382A2 Compounds useful in the treatment of anthrax and inhibiting lethal factor
12/11/2003WO2003101375A2 Immunostimulatory oligonucleotides and uses thereof
12/11/2003WO2003101356A1 Personal care article and method for inhibiting attachment of yeast to skin
12/11/2003WO2003080823A3 Bacteriophages useful for therapy and prophylaxis of bacterial infections
12/11/2003WO2003063772A3 Methods for blocking or alleviating staphylococcal nasal colonization by intranasal application of monoclonal antibodies
12/11/2003WO2003057666A3 Inhibitors of dipeptidyl peptidase iv
12/11/2003WO2003051300A3 Metal complexes and formulations of rifamycin analogues and uses therof
12/11/2003WO2003051289A3 Solubilized topoisomerase poison agents
12/11/2003WO2003044053A3 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
12/11/2003WO2003044048A3 Methylated heparin-binding hemagglutinin (hbha) recombinant mycobacterial antigen
12/11/2003WO2003027090A3 Bicyclic heterocycles as rxr ligands
12/11/2003WO2003026579A3 Combination therapies for immune mediated diseases
12/11/2003WO2003025218A3 Methods and yeast strains for screening antifungal agents
12/11/2003WO2003024395A3 Linked biaryl compounds
12/11/2003WO2003023042A9 Recombinant mva capable of expressing structural hcv antigens
12/11/2003WO2003022883A3 Use of proteins for the production of a medicament for stimulating the innate non specific immune system
12/11/2003WO2003011226A3 Products and drug delivery vehicles
12/11/2003WO2002094190A3 Heterologous protection induced by immunization with invaplex vaccine
12/11/2003WO2002087508A3 Nitrosated and nitrosylated nebivolol and its metabolites, compositions and methods of use
12/11/2003WO2002087465A3 Compositions and methods of double-targeting virus infections and cancer cells
12/11/2003WO2002085925A3 Melanocortin receptor ligands
12/11/2003WO2002083841A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
12/11/2003WO2002080883A3 Method and composition for solubilising a biologically active compound with low water solubility
12/11/2003WO2002078648A3 Topical composition comprising an antifungal
12/11/2003WO2002075507B1 Anti-bacterial vaccine compositions
12/11/2003WO2002067986A3 Symbiotic regenerative agent
12/11/2003WO2002053149A3 Medicament containing a polyamine as an active substance
12/11/2003WO2002048165A8 Antiviral agents for treatment of flaviviridae infections
12/11/2003US20030229231 Forming chelate compounds
12/11/2003US20030229225 Novel phosphonic acid based prodrugs of PMEA and its analogues
12/11/2003US20030229220 Oligomer phosphoramidite compositions and processes for synthesizing the same
12/11/2003US20030229134 Methods for stimulating nervous system regeneration and repair by inhibiting phosphodiesterase type 4
12/11/2003US20030229115 Organ rejection disease; autoimmune disease; immunosuppressants
12/11/2003US20030229110 Cell signal transduction
12/11/2003US20030229092 Antidiabetic agents; antiinflammatory agents; analgesics; antiallergens
12/11/2003US20030229079 1-(Aromatic- or heteroaromatic-substituted)-3-(heteroaromatic substituted)-1,3-propanediones and uses thereof
12/11/2003US20030229073 Tricyclic compounds and method of treating herpes virus
12/11/2003US20030229065 Measuring drug resistance, calibration; reducing antibiotic resistance
12/11/2003US20030229053 Compounds and methods for the treatment or prevention of flavivirus infections
12/11/2003US20030229047 Liquid formulation of decitabine and use of the same
12/11/2003US20030229043 Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes
12/11/2003US20030229031 13-Methyl erythromycin derivatives
12/11/2003US20030228634 Expression vectors encoding epitopes of target-associated antigens and methods for their design
12/11/2003US20030228625 Method for diagnosing and monitoring hemostatic dysfunction, severe infection and systematic inflammatory response syndrome
12/11/2003US20030228576 Nucleotide sequence coding for a cleaving enzyme; can use in conjuction with substrate to produce toxins which impair abnormal cell growth; antitumor agents
12/11/2003US20030228573 Contacting test compound with Gag283 and determining its ability to bind to the apical cleft near the C-terminal domain; use in treatment of Acquired Immunodeficiency Syndrome (AIDS)
12/11/2003US20030228382 Foot Fixer Kit
1 ... 1116 1117 1118 1119 1120 1121 1122 1123 1124 1125 1126 1127 1128 1129 1130 1131 1132 1133 1134 1135 1136 ... 1798